ELENA SHEETS: Open Payments
NPI 1497260038 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 37 payments from 10 companies in 2025. Trend: 2023 $1,423 · 2024 $918 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $428 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| PFIZER INC. | 3 | $44 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
| Abbott Laboratories | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| QOL Medical, LLC | 1 | $13 |
Products named: RINVOQ, TREMFYA, ENTYVIO, CREON, SKYRIZI, VOQUEZNA, VELSIPITY, ULTREON.
Industry payments across TX — which companies pay providers there.
